FDA OKs System That Can Sense When Drugs Are Taken

Law360, New York (July 31, 2012, 8:15 PM EDT) -- A California startup with financial backing from Novartis said Monday it had won U.S. Food and Drug Administration approval to market a digitized pill that can keep better track of a patient's adherence to medications, widely recognized as a major obstacle to improving the quality of care.

Proteus Digital Health Inc. said its ingestible sensor system could improve the ability of patients, especially those with chronic conditions, to take their medications as prescribed.

“Directly digitizing pills, for the first time, in conjunction with our wireless infrastructure,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.